Document Detail


The early and late effects of digoxin treatment on the sodium transport, sodium content and Na+K+- ATPase or erythrocytes.
MedLine Citation:
PMID:  6268133     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1 Erythrocyte sodium content, sodium transport (ouabain sensitive sodium flux Eos, and ouabain sensitive efflux rate constant ERCos) sodium, potassium activated ouabain sensitive adenosine triphosphatase (Na+K+ATPase) and plasma digoxin were measured in patients during acute digitalisation and in patients who were on long-term digoxin treatment. 2 In the six patients who were studied during digitalisation, the ERCos and Na+K+ATPase activity decreased and erythrocyte sodium content increased during days 2-4 treatment, but there was no change in Eos. 3 In 39 patients on long term digoxin therapy (2-119 months) the erythrocyte sodium content was normal, but the erythrocyte Na+K+ATPase activity was higher than the control group. When the results from these 39 patients were divided according to the duration of treatment it was found that the erythrocyte sodium content was higher in patients treated for 2-4 months than in patients treated for longer periods and the erythrocyte Na+K+ATPase activity increased with duration of treatment. In eight patients (duration of treatment greater than 29 months) in whom ERCos and Eos were measured, ERCos and Eos were higher than the control group. 4 The results suggest that the effects of digoxin on erythrocytes which occur during acute digoxin treatment do not persist in the long term. 5 The possible explanation for the higher ERCos, Eos and Na+K+ATPase activity in patients treated with digoxin for more than 2 months is discussed.
Authors:
M Cumberbatch; K Zareian; C Davidson; D B Morgan; R Swaminathan
Related Documents :
20228513 - The role of theophylline in prevention of radiocontrast media-induced nephropathy.
20596643 - Pharmacokinetics of s-1 and cyp2a6 genotype in japanese patients with advanced cancer.
24692573 - Standard and pocket-size lung ultrasound devices can detect interstitial lung disease i...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  11     ISSN:  0306-5251     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  1981 Jun 
Date Detail:
Created Date:  1981-11-18     Completed Date:  1981-11-18     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  565-70     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biological Transport / drug effects
Digoxin / pharmacology*
Erythrocytes / drug effects,  metabolism*
Humans
Middle Aged
Sodium / blood*
Sodium-Potassium-Exchanging ATPase / blood*
Time Factors
Chemical
Reg. No./Substance:
20830-75-5/Digoxin; 7440-23-5/Sodium; EC 3.6.3.9/Sodium-Potassium-Exchanging ATPase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the compon...
Next Document:  Effects of cyclic-nucleotide derivatives on the growth of human colonic carcinoma xenografts and on ...